These results suggest that DUSP16 may have similar function in NPC, CRC, and gastric cancer in response to various chemotherapeutic agents and the level of DUSP16 could serve as a marker for sensitivity to chemotherapy in these cancers. This evidence concerns the gene DUSP16 and gastric cancer.